DarshanTalks Podcast

406 Episodo

1. Will New Tariffs Disrupt Your Next Pharma Deal?

   Publicado: 26/2/2025
2. Protecting Patient Data in a Changing Regulatory Landscape

   Publicado: 25/2/2025
3. Off-Label Promotion Changes in 2025

   Publicado: 24/2/2025
4. Turning Physicians into Leaders

   Publicado: 21/2/2025
5. Key Regulatory Agencies in Pharma M&A

   Publicado: 20/2/2025
6. Does E6 (R3) Blur the Line Between GCP and Privacy Laws?

   Publicado: 19/2/2025
7. RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy

   Publicado: 18/2/2025
8. America’s Research Future in Jeopardy

   Publicado: 15/2/2025
9. Trump Administration’s NIH cuts: Will they cripple US medical research?

   Publicado: 14/2/2025
10. DEI Under Trump: What It Means for Clinical Trials

    Publicado: 13/2/2025
11. CAPA & RCA: A Must for Pharma M&A

    Publicado: 12/2/2025
12. Trump Targets Indirect Costs in NIH Funding

    Publicado: 11/2/2025
13. The USAID Halt and Its Consequences for Clinical Research

    Publicado: 10/2/2025
14. Ebola Vaccine Trial in Record Time!

    Publicado: 8/2/2025
15. Your Clinical Trial Site M&A Agreement is Exposing You to Risk

    Publicado: 7/2/2025
16. What Does ICH E6 R3 Say About Returning Data to Participants?

    Publicado: 5/2/2025
17. Navigating the Ongoing HHS Communication Freeze

    Publicado: 4/2/2025
18. Ordinary People Are Changing Medicine

    Publicado: 3/2/2025
19. Trump’s First 10 Days: The Impact on Clinical Trials

    Publicado: 31/1/2025
20. Selling a Business with Issues

    Publicado: 31/1/2025